Wendell A. Lim

Molecular Biology · 1990–2018

A researcher in the Science corpus: 17 papers; trusts 20 researchers and is trusted by 8 researchers here, as inferred from the citation graph.

Subfields

Molecular Biology — 183 citations into it; #7,993 of 17,773 by trust here, #1,638 by citations
Oncology — 101 citations into it; #677 of 1,698 by trust here, #799 by citations
Immunology — 84 citations into it; #981 of 2,160 by trust here, #1,346 by citations
Genetics — 55 citations into it
Radiology, Nuclear Medicine and Imaging — 15 citations into it
Cellular and Molecular Neuroscience — 13 citations into it
Materials Chemistry — 7 citations into it

Whom Wendell A. Lim trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts Wendell A. Lim overall

Papers from Wendell A. Lim's perspective

Ordered by how strongly the researchers Wendell A. Lim trusts endorse each paper. Same corpus, a different order for every researcher.

Cancer regression and neurologic toxicity following anti-MAGE-A3 TCR gene therapy (Journal of immunotherapy)
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
T cell exhaustion (Nature Immunology)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (Science Translational Medicine)
The CD28 signaling pathway regulates glucose metabolism. (Immunity)
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. (Journal of Clinical Oncology)
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (Clinical Cancer Research)
Mitochondrial Respiratory Capacity Is A Critical Regulator Of CD8+ T Cell Memory Development (Immunity)
Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells (Science Translational Medicine)
Precision Tumor Recognition by T Cells With Combinatorial Antigen Sensing Circuits (Cell)

Their papers

CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes (2013) — 3,520 citations
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. (2013) — 4,744 citations
Control of protein signaling using a computationally designed GTPase/GEF orthogonal pair (2012) — 86 citations
The Principles of Engineering Immune Cells to Treat Cancer (2017) — 970 citations
Defining Network Topologies that Can Achieve Biochemical Adaptation (2009) — 970 citations
Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information (2011) — 847 citations
The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans (2008) — 1,101 citations
Programming self-organizing multicellular structures with synthetic cell-cell signaling (2018) — 404 citations
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells (2016) — 652 citations
CRISPR interference (CRISPRi) for sequence-specific control of gene expression (2013) — 1,150 citations
Precision Tumor Recognition by T Cells With Combinatorial Antigen Sensing Circuits (2016) — 918 citations
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors (2016) — 907 citations
Engineering T cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors (2016) — 665 citations
Remote control of therapeutic T cells through a small molecule-gated chimeric receptor (2015) — 660 citations
Spatiotemporal Control of Cell Signalling Using A Light-Switchable Protein Interaction (2009) — 998 citations
Mechanism and role of PDZ domains in signaling complex assembly. (2001) — 882 citations
Deciphering the message in protein sequences: tolerance to amino acid substitutions. (1990)